Assignee
SECOND GENOME INC
US·10 granted patents·12 pending applications·12 citations·filing 2014–2023
Top patents by PatentIndex Score
22 records- 0188US11174293B2Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2018·Granted Nov 16, 2021·3 cites·16 claims
- 0288US10251933B2Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2018·Granted Apr 9, 2019·4 cites·18 claims
- 0377US11273198B2Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2018·Granted Mar 15, 2022·2 cites·13 claims
- 0477US11207376B2Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2018·Granted Dec 28, 2021·1 cites·24 claims
- 0574US2024066095A1Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2023·Application pending·0 cites
- 0670US11666627B2Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2019·Granted Jun 6, 2023·1 cites·16 claims
- 0769US11505583B2Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2019·Granted Nov 22, 2022·1 cites·16 claims
- 0868US2022106365A1Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2021·Application pending·0 cites
- 0962US11344584B2Gemella sanguinis as a biotherapeuticSECOND GENOME INC·Filed 2018·Granted May 31, 2022·0 cites·19 claims
- 1057US10150982B2Microbial ecology shift assaySECOND GENOME INC·Filed 2014·Granted Dec 11, 2018·0 cites·21 claims
- 1156US2022185849A1Proteins for the treatment of epithelial barrier function disordersSECOND GENOME INC·Filed 2018·Application pending·0 cites
- 1255US2019136287A1Microbial Ecology Shift AssaySECOND GENOME INC·Filed 2018·Application pending·0 cites
- 1345US2023272016A1Peptides for immunotherapySECOND GENOME INC·Filed 2021·Application pending·0 cites
- 1444US11389487B2Streptococcus australis as a biotherapeuticSECOND GENOME INC·Filed 2018·Granted Jul 19, 2022·0 cites·19 claims
- 1542US2015337349A1Microbiome Modulation IndexSECOND GENOME INC·Filed 2014·Application pending·0 cites
- 1642US2023031818A1Methods and compositions for treating colorectal cancerSECOND GENOME INC·Filed 2021·Application pending·0 cites
- 1739US2023030056A1Methods and compositions for treating ulcerative colitisSECOND GENOME INC·Filed 2021·Application pending·0 cites
- 1839US2023035667A1Methods and compositions for treating type 2 diabetesSECOND GENOME INC·Filed 2021·Application pending·0 cites
- 1937US2021268037A1Anaerostipes hadrus for use in promoting healthSECOND GENOME INC·Filed 2019·Application pending·0 cites
- 2036US11473133B2Methods for validation of microbiome sequence processing and differential abundance analyses via multiple bespoke spike-in mixturesSECOND GENOME INC·Filed 2019·Granted Oct 18, 2022·0 cites·13 claims
- 2133US2023033663A1Methods and compositions for treating atopic dermatitisSECOND GENOME INC·Filed 2021·Application pending·0 cites
- 2233US2020011873A1Leveraging sequence-based fecal microbial community survey data to identify a composite biomarker for colorectal cancerSECOND GENOME INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SECOND GENOME INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →